Skip to search.
 FTSE 100 Down 0.06%

More On AZN

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

AstraZeneca PLC (AZN)

-NYSE
25.82 Down 0.07(0.27%) 5 Dec 21:02
|Pre-Market : 25.79 Down 0.03 (0.12%) 10:12 - Nasdaq Real Time Price
Prev Close:25.89
Open:26.03
Bid:25.88 x 1000
Ask:25.89 x 200
1y Target Est:34.12
Beta:0.558165
Next Earnings Date:N/A
Day's Range:25.68 - 26.04
52wk Range:25.68 - 35.04
Volume:7,987,640
Avg Vol (3m):6,246,500
Market Cap:67.21b
P/E (ttm):26.50
EPS (ttm):0.97
Div & Yield:0.90 (3.48%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 0.27%67.21b
GSKDown 0.08%89.76b
PFEDown 0.13%191.70b
MRKDown 1.44%166.12b

Key Statistics

Forward P/E (1 yr):14.03
P/S (ttm):2.75
Ex-Dividend Date:10-Aug-16

Analysts

Annual EPS Est (Dec-16) :2.07
Quarterly EPS Est (Dec-16) :0.59
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-12.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal d... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback